2015-2027 Global RNA-interference (RNAi) Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
The worldwide market for RNA-interference (RNAi) is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
Thermo Fisher Scientific Inc.
Arcturus Therapeutics
Qiagen NV
Silence Therapeutics PLC
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Phio Pharmaceuticals Corp.
Arrowhead
Ionis Pharmaceuticals Inc.
Quark Pharmaceuticals Inc.
Tekmira Pharmaceuticals Corporation
RXI Pharmaceuticals
ISIS Pharmaceuticals
Dicerna Pharmaceuticals
Merck & Co. Inc. (Sigma Aldrich)
Major Types Covered
Chemical synthesis
In vitro transcription
In vivo expression
Major Applications Covered
Drug Discovery and Development
Therapeutics
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
Thermo Fisher Scientific Inc.
Arcturus Therapeutics
Qiagen NV
Silence Therapeutics PLC
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Phio Pharmaceuticals Corp.
Arrowhead
Ionis Pharmaceuticals Inc.
Quark Pharmaceuticals Inc.
Tekmira Pharmaceuticals Corporation
RXI Pharmaceuticals
ISIS Pharmaceuticals
Dicerna Pharmaceuticals
Merck & Co. Inc. (Sigma Aldrich)
Major Types Covered
Chemical synthesis
In vitro transcription
In vivo expression
Major Applications Covered
Drug Discovery and Development
Therapeutics
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global RNA-interference (RNAi) Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the RNA-interference (RNAi) Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE RNA-INTERFERENCE (RNAI) MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL RNA-INTERFERENCE (RNAI) MARKET-SEGMENTATION BY TYPE
5.1 Chemical synthesis
5.2 In vitro transcription
5.3 In vivo expression
6 GLOBAL RNA-INTERFERENCE (RNAI) MARKET-SEGMENTATION BY APPLICATION
6.1 Drug Discovery and Development
6.2 Therapeutics
7 GLOBAL RNA-INTERFERENCE (RNAI) MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 Thermo Fisher Scientific Inc.
8.1.1 Thermo Fisher Scientific Inc. Profile
8.1.2 Thermo Fisher Scientific Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Thermo Fisher Scientific Inc. Product/Solution Launches and Enhancements Analysis
8.1.4 Thermo Fisher Scientific Inc. Business Overview/Recent Development/Acquisitions
8.2 Arcturus Therapeutics
8.2.1 Arcturus Therapeutics Profile
8.2.2 Arcturus Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Arcturus Therapeutics Product/Solution Launches and Enhancements Analysis
8.2.4 Arcturus Therapeutics Business Overview/Recent Development/Acquisitions
8.3 Qiagen NV
8.3.1 Qiagen NV Profile
8.3.2 Qiagen NV Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Qiagen NV Product/Solution Launches and Enhancements Analysis
8.3.4 Qiagen NV Business Overview/Recent Development/Acquisitions
8.4 Silence Therapeutics PLC
8.4.1 Silence Therapeutics PLC Profile
8.4.2 Silence Therapeutics PLC Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Silence Therapeutics PLC Product/Solution Launches and Enhancements Analysis
8.4.4 Silence Therapeutics PLC Business Overview/Recent Development/Acquisitions
8.5 Alnylam Pharmaceuticals
8.5.1 Alnylam Pharmaceuticals Profile
8.5.2 Alnylam Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Alnylam Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.5.4 Alnylam Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.6 Benitec Biopharma Ltd
8.6.1 Benitec Biopharma Ltd Profile
8.6.2 Benitec Biopharma Ltd Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Benitec Biopharma Ltd Product/Solution Launches and Enhancements Analysis
8.6.4 Benitec Biopharma Ltd Business Overview/Recent Development/Acquisitions
8.7 Phio Pharmaceuticals Corp.
8.7.1 Phio Pharmaceuticals Corp. Profile
8.7.2 Phio Pharmaceuticals Corp. Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Phio Pharmaceuticals Corp. Product/Solution Launches and Enhancements Analysis
8.7.4 Phio Pharmaceuticals Corp. Business Overview/Recent Development/Acquisitions
8.8 Arrowhead
8.8.1 Arrowhead Profile
8.8.2 Arrowhead Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Arrowhead Product/Solution Launches and Enhancements Analysis
8.8.4 Arrowhead Business Overview/Recent Development/Acquisitions
8.9 Ionis Pharmaceuticals Inc.
8.9.1 Ionis Pharmaceuticals Inc. Profile
8.9.2 Ionis Pharmaceuticals Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Ionis Pharmaceuticals Inc. Product/Solution Launches and Enhancements Analysis
8.9.4 Ionis Pharmaceuticals Inc. Business Overview/Recent Development/Acquisitions
8.10 Quark Pharmaceuticals Inc.
8.10.1 Quark Pharmaceuticals Inc. Profile
8.10.2 Quark Pharmaceuticals Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Quark Pharmaceuticals Inc. Product/Solution Launches and Enhancements Analysis
8.10.4 Quark Pharmaceuticals Inc. Business Overview/Recent Development/Acquisitions
8.11 Tekmira Pharmaceuticals Corporation
8.11.1 Tekmira Pharmaceuticals Corporation Profile
8.11.2 Tekmira Pharmaceuticals Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Tekmira Pharmaceuticals Corporation Product/Solution Launches and Enhancements Analysis
8.11.4 Tekmira Pharmaceuticals Corporation Business Overview/Recent Development/Acquisitions
8.12 RXI Pharmaceuticals
8.12.1 RXI Pharmaceuticals Profile
8.12.2 RXI Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 RXI Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.12.4 RXI Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.13 ISIS Pharmaceuticals
8.13.1 ISIS Pharmaceuticals Profile
8.13.2 ISIS Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 ISIS Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.13.4 ISIS Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.14 Dicerna Pharmaceuticals
8.14.1 Dicerna Pharmaceuticals Profile
8.14.2 Dicerna Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Dicerna Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.14.4 Dicerna Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.15 Merck & Co. Inc. (Sigma Aldrich)
8.15.1 Merck & Co. Inc. (Sigma Aldrich) Profile
8.15.2 Merck & Co. Inc. (Sigma Aldrich) Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Merck & Co. Inc. (Sigma Aldrich) Product/Solution Launches and Enhancements Analysis
8.15.4 Merck & Co. Inc. (Sigma Aldrich) Business Overview/Recent Development/Acquisitions
9 GLOBAL RNA-INTERFERENCE (RNAI) MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America RNA-interference (RNAi) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America RNA-interference (RNAi) Production Analysis from 2015-2020
10.4 North America RNA-interference (RNAi) Consumption Analysis from 2015-2020
10.5 North America RNA-interference (RNAi) Import and Export from 2015-2020
10.6 North America RNA-interference (RNAi) Value, Production and Market Share by Type (2015-2020)
10.7 North America RNA-interference (RNAi) Consumption, Value and Market Share by Application (2015-2020)
10.8 North America RNA-interference (RNAi) by Country (United States, Canada)
10.8.1 North America RNA-interference (RNAi) Sales by Country (2015-2020)
10.8.2 North America RNA-interference (RNAi) Consumption Value by Country (2015-2020)
10.9 North America RNA-interference (RNAi) Market PEST Analysis
11 EUROPE
11.1 Europe RNA-interference (RNAi) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe RNA-interference (RNAi) Production Analysis from 2015-2020
11.4 Europe RNA-interference (RNAi) Consumption Analysis from 2015-2020
11.5 Europe RNA-interference (RNAi) Import and Export from 2015-2020
11.6 Europe RNA-interference (RNAi) Value, Production and Market Share by Type (2015-2020)
11.7 Europe RNA-interference (RNAi) Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe RNA-interference (RNAi) by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe RNA-interference (RNAi) Sales by Country (2015-2020)
11.8.2 Europe RNA-interference (RNAi) Consumption Value by Country (2015-2020)
11.9 Europe RNA-interference (RNAi) Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific RNA-interference (RNAi) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific RNA-interference (RNAi) Production Analysis from 2015-2020
12.4 Asia-Pacific RNA-interference (RNAi) Consumption Analysis from 2015-2020
12.5 Asia-Pacific RNA-interference (RNAi) Import and Export from 2015-2020
12.6 Asia-Pacific RNA-interference (RNAi) Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific RNA-interference (RNAi) Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific RNA-interference (RNAi) by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific RNA-interference (RNAi) Sales by Country (2015-2020)
12.8.2 Asia-Pacific RNA-interference (RNAi) Consumption Value by Country (2015-2020)
12.9 Asia-Pacific RNA-interference (RNAi) Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America RNA-interference (RNAi) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America RNA-interference (RNAi) Production Analysis from 2015-2020
13.4 Latin America RNA-interference (RNAi) Consumption Analysis from 2015-2020
13.5 Latin America RNA-interference (RNAi) Import and Export from 2015-2020
13.6 Latin America RNA-interference (RNAi) Value, Production and Market Share by Type (2015-2020)
13.7 Latin America RNA-interference (RNAi) Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America RNA-interference (RNAi) by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America RNA-interference (RNAi) Sales by Country (2015-2020)
13.8.2 Latin America RNA-interference (RNAi) Consumption Value by Country (2015-2020)
13.9 Latin America RNA-interference (RNAi) Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa RNA-interference (RNAi) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa RNA-interference (RNAi) Production Analysis from 2015-2020
14.4 Middle East & Africa RNA-interference (RNAi) Consumption Analysis from 2015-2020
14.5 Middle East & Africa RNA-interference (RNAi) Import and Export from 2015-2020
14.6 Middle East & Africa RNA-interference (RNAi) Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa RNA-interference (RNAi) Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa RNA-interference (RNAi) by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa RNA-interference (RNAi) Sales by Country (2015-2020)
14.8.2 Middle East & Africa RNA-interference (RNAi) Consumption Value by Country (2015-2020)
14.9 Middle East & Africa RNA-interference (RNAi) Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL RNA-INTERFERENCE (RNAI) MARKET FROM 2020-2027
15.1 Future Forecast of the Global RNA-interference (RNAi) Market from 2020-2027 Segment by Region
15.2 Global RNA-interference (RNAi) Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global RNA-interference (RNAi) Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global RNA-interference (RNAi) Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the RNA-interference (RNAi) Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE RNA-INTERFERENCE (RNAI) MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL RNA-INTERFERENCE (RNAI) MARKET-SEGMENTATION BY TYPE
5.1 Chemical synthesis
5.2 In vitro transcription
5.3 In vivo expression
6 GLOBAL RNA-INTERFERENCE (RNAI) MARKET-SEGMENTATION BY APPLICATION
6.1 Drug Discovery and Development
6.2 Therapeutics
7 GLOBAL RNA-INTERFERENCE (RNAI) MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 Thermo Fisher Scientific Inc.
8.1.1 Thermo Fisher Scientific Inc. Profile
8.1.2 Thermo Fisher Scientific Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Thermo Fisher Scientific Inc. Product/Solution Launches and Enhancements Analysis
8.1.4 Thermo Fisher Scientific Inc. Business Overview/Recent Development/Acquisitions
8.2 Arcturus Therapeutics
8.2.1 Arcturus Therapeutics Profile
8.2.2 Arcturus Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Arcturus Therapeutics Product/Solution Launches and Enhancements Analysis
8.2.4 Arcturus Therapeutics Business Overview/Recent Development/Acquisitions
8.3 Qiagen NV
8.3.1 Qiagen NV Profile
8.3.2 Qiagen NV Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Qiagen NV Product/Solution Launches and Enhancements Analysis
8.3.4 Qiagen NV Business Overview/Recent Development/Acquisitions
8.4 Silence Therapeutics PLC
8.4.1 Silence Therapeutics PLC Profile
8.4.2 Silence Therapeutics PLC Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Silence Therapeutics PLC Product/Solution Launches and Enhancements Analysis
8.4.4 Silence Therapeutics PLC Business Overview/Recent Development/Acquisitions
8.5 Alnylam Pharmaceuticals
8.5.1 Alnylam Pharmaceuticals Profile
8.5.2 Alnylam Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Alnylam Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.5.4 Alnylam Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.6 Benitec Biopharma Ltd
8.6.1 Benitec Biopharma Ltd Profile
8.6.2 Benitec Biopharma Ltd Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Benitec Biopharma Ltd Product/Solution Launches and Enhancements Analysis
8.6.4 Benitec Biopharma Ltd Business Overview/Recent Development/Acquisitions
8.7 Phio Pharmaceuticals Corp.
8.7.1 Phio Pharmaceuticals Corp. Profile
8.7.2 Phio Pharmaceuticals Corp. Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Phio Pharmaceuticals Corp. Product/Solution Launches and Enhancements Analysis
8.7.4 Phio Pharmaceuticals Corp. Business Overview/Recent Development/Acquisitions
8.8 Arrowhead
8.8.1 Arrowhead Profile
8.8.2 Arrowhead Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Arrowhead Product/Solution Launches and Enhancements Analysis
8.8.4 Arrowhead Business Overview/Recent Development/Acquisitions
8.9 Ionis Pharmaceuticals Inc.
8.9.1 Ionis Pharmaceuticals Inc. Profile
8.9.2 Ionis Pharmaceuticals Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Ionis Pharmaceuticals Inc. Product/Solution Launches and Enhancements Analysis
8.9.4 Ionis Pharmaceuticals Inc. Business Overview/Recent Development/Acquisitions
8.10 Quark Pharmaceuticals Inc.
8.10.1 Quark Pharmaceuticals Inc. Profile
8.10.2 Quark Pharmaceuticals Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Quark Pharmaceuticals Inc. Product/Solution Launches and Enhancements Analysis
8.10.4 Quark Pharmaceuticals Inc. Business Overview/Recent Development/Acquisitions
8.11 Tekmira Pharmaceuticals Corporation
8.11.1 Tekmira Pharmaceuticals Corporation Profile
8.11.2 Tekmira Pharmaceuticals Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Tekmira Pharmaceuticals Corporation Product/Solution Launches and Enhancements Analysis
8.11.4 Tekmira Pharmaceuticals Corporation Business Overview/Recent Development/Acquisitions
8.12 RXI Pharmaceuticals
8.12.1 RXI Pharmaceuticals Profile
8.12.2 RXI Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 RXI Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.12.4 RXI Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.13 ISIS Pharmaceuticals
8.13.1 ISIS Pharmaceuticals Profile
8.13.2 ISIS Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 ISIS Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.13.4 ISIS Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.14 Dicerna Pharmaceuticals
8.14.1 Dicerna Pharmaceuticals Profile
8.14.2 Dicerna Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Dicerna Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.14.4 Dicerna Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.15 Merck & Co. Inc. (Sigma Aldrich)
8.15.1 Merck & Co. Inc. (Sigma Aldrich) Profile
8.15.2 Merck & Co. Inc. (Sigma Aldrich) Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Merck & Co. Inc. (Sigma Aldrich) Product/Solution Launches and Enhancements Analysis
8.15.4 Merck & Co. Inc. (Sigma Aldrich) Business Overview/Recent Development/Acquisitions
9 GLOBAL RNA-INTERFERENCE (RNAI) MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America RNA-interference (RNAi) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America RNA-interference (RNAi) Production Analysis from 2015-2020
10.4 North America RNA-interference (RNAi) Consumption Analysis from 2015-2020
10.5 North America RNA-interference (RNAi) Import and Export from 2015-2020
10.6 North America RNA-interference (RNAi) Value, Production and Market Share by Type (2015-2020)
10.7 North America RNA-interference (RNAi) Consumption, Value and Market Share by Application (2015-2020)
10.8 North America RNA-interference (RNAi) by Country (United States, Canada)
10.8.1 North America RNA-interference (RNAi) Sales by Country (2015-2020)
10.8.2 North America RNA-interference (RNAi) Consumption Value by Country (2015-2020)
10.9 North America RNA-interference (RNAi) Market PEST Analysis
11 EUROPE
11.1 Europe RNA-interference (RNAi) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe RNA-interference (RNAi) Production Analysis from 2015-2020
11.4 Europe RNA-interference (RNAi) Consumption Analysis from 2015-2020
11.5 Europe RNA-interference (RNAi) Import and Export from 2015-2020
11.6 Europe RNA-interference (RNAi) Value, Production and Market Share by Type (2015-2020)
11.7 Europe RNA-interference (RNAi) Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe RNA-interference (RNAi) by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe RNA-interference (RNAi) Sales by Country (2015-2020)
11.8.2 Europe RNA-interference (RNAi) Consumption Value by Country (2015-2020)
11.9 Europe RNA-interference (RNAi) Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific RNA-interference (RNAi) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific RNA-interference (RNAi) Production Analysis from 2015-2020
12.4 Asia-Pacific RNA-interference (RNAi) Consumption Analysis from 2015-2020
12.5 Asia-Pacific RNA-interference (RNAi) Import and Export from 2015-2020
12.6 Asia-Pacific RNA-interference (RNAi) Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific RNA-interference (RNAi) Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific RNA-interference (RNAi) by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific RNA-interference (RNAi) Sales by Country (2015-2020)
12.8.2 Asia-Pacific RNA-interference (RNAi) Consumption Value by Country (2015-2020)
12.9 Asia-Pacific RNA-interference (RNAi) Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America RNA-interference (RNAi) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America RNA-interference (RNAi) Production Analysis from 2015-2020
13.4 Latin America RNA-interference (RNAi) Consumption Analysis from 2015-2020
13.5 Latin America RNA-interference (RNAi) Import and Export from 2015-2020
13.6 Latin America RNA-interference (RNAi) Value, Production and Market Share by Type (2015-2020)
13.7 Latin America RNA-interference (RNAi) Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America RNA-interference (RNAi) by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America RNA-interference (RNAi) Sales by Country (2015-2020)
13.8.2 Latin America RNA-interference (RNAi) Consumption Value by Country (2015-2020)
13.9 Latin America RNA-interference (RNAi) Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa RNA-interference (RNAi) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa RNA-interference (RNAi) Production Analysis from 2015-2020
14.4 Middle East & Africa RNA-interference (RNAi) Consumption Analysis from 2015-2020
14.5 Middle East & Africa RNA-interference (RNAi) Import and Export from 2015-2020
14.6 Middle East & Africa RNA-interference (RNAi) Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa RNA-interference (RNAi) Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa RNA-interference (RNAi) by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa RNA-interference (RNAi) Sales by Country (2015-2020)
14.8.2 Middle East & Africa RNA-interference (RNAi) Consumption Value by Country (2015-2020)
14.9 Middle East & Africa RNA-interference (RNAi) Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL RNA-INTERFERENCE (RNAI) MARKET FROM 2020-2027
15.1 Future Forecast of the Global RNA-interference (RNAi) Market from 2020-2027 Segment by Region
15.2 Global RNA-interference (RNAi) Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global RNA-interference (RNAi) Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
LIST OF TABLES AND FIGURES
Global RNA-interference (RNAi) Market Value ($) and Growth Rate of RNA-interference (RNAi) from 2015-2027
Global RNA-interference (RNAi) Production and Growth Rate Segment by Product Type from 2015-2027
Global RNA-interference (RNAi) Consumption and Growth Rate Segment by Application from 2015-2027
Figure RNA-interference (RNAi) Picture
Table Product Specifications of RNA-interference (RNAi)
Table Driving Factors for this Market
Table Industry News of RNA-interference (RNAi) Market
Figure Value Chain Status of RNA-interference (RNAi)
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global RNA-interference (RNAi) Production and Growth Rate Segment by Product Type from 2015-2020
Table Global RNA-interference (RNAi) Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Chemical synthesis of RNA-interference (RNAi)
Figure In vitro transcription of RNA-interference (RNAi)
Figure In vivo expression of RNA-interference (RNAi)
Table Global RNA-interference (RNAi) Consumption and Growth Rate Segment by Application from 2015-2020
Table Global RNA-interference (RNAi) Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Drug Discovery and Development of RNA-interference (RNAi)
Figure Therapeutics of RNA-interference (RNAi)
Table Global RNA-interference (RNAi) Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global RNA-interference (RNAi) Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of RNA-interference (RNAi)
Figure Online Channel of RNA-interference (RNAi)
Table Thermo Fisher Scientific Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Thermo Fisher Scientific Inc. Sales and Growth Rate from 2015-2020
Figure Thermo Fisher Scientific Inc. Revenue ($) and Global Market Share from 2015-2020
Table Thermo Fisher Scientific Inc. RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Arcturus Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Arcturus Therapeutics Sales and Growth Rate from 2015-2020
Figure Arcturus Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Arcturus Therapeutics RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Qiagen NV Profile (Company Name, Plants Distribution, Sales Region)
Figure Qiagen NV Sales and Growth Rate from 2015-2020
Figure Qiagen NV Revenue ($) and Global Market Share from 2015-2020
Table Qiagen NV RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Silence Therapeutics PLC Profile (Company Name, Plants Distribution, Sales Region)
Figure Silence Therapeutics PLC Sales and Growth Rate from 2015-2020
Figure Silence Therapeutics PLC Revenue ($) and Global Market Share from 2015-2020
Table Silence Therapeutics PLC RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Alnylam Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Alnylam Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Alnylam Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Alnylam Pharmaceuticals RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Benitec Biopharma Ltd Profile (Company Name, Plants Distribution, Sales Region)
Figure Benitec Biopharma Ltd Sales and Growth Rate from 2015-2020
Figure Benitec Biopharma Ltd Revenue ($) and Global Market Share from 2015-2020
Table Benitec Biopharma Ltd RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Phio Pharmaceuticals Corp. Profile (Company Name, Plants Distribution, Sales Region)
Figure Phio Pharmaceuticals Corp. Sales and Growth Rate from 2015-2020
Figure Phio Pharmaceuticals Corp. Revenue ($) and Global Market Share from 2015-2020
Table Phio Pharmaceuticals Corp. RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Arrowhead Profile (Company Name, Plants Distribution, Sales Region)
Figure Arrowhead Sales and Growth Rate from 2015-2020
Figure Arrowhead Revenue ($) and Global Market Share from 2015-2020
Table Arrowhead RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ionis Pharmaceuticals Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Ionis Pharmaceuticals Inc. Sales and Growth Rate from 2015-2020
Figure Ionis Pharmaceuticals Inc. Revenue ($) and Global Market Share from 2015-2020
Table Ionis Pharmaceuticals Inc. RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Quark Pharmaceuticals Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Quark Pharmaceuticals Inc. Sales and Growth Rate from 2015-2020
Figure Quark Pharmaceuticals Inc. Revenue ($) and Global Market Share from 2015-2020
Table Quark Pharmaceuticals Inc. RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Tekmira Pharmaceuticals Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Tekmira Pharmaceuticals Corporation Sales and Growth Rate from 2015-2020
Figure Tekmira Pharmaceuticals Corporation Revenue ($) and Global Market Share from 2015-2020
Table Tekmira Pharmaceuticals Corporation RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table RXI Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure RXI Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure RXI Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table RXI Pharmaceuticals RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table ISIS Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure ISIS Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure ISIS Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table ISIS Pharmaceuticals RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Dicerna Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Dicerna Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Dicerna Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Dicerna Pharmaceuticals RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck & Co. Inc. (Sigma Aldrich) Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck & Co. Inc. (Sigma Aldrich) Sales and Growth Rate from 2015-2020
Figure Merck & Co. Inc. (Sigma Aldrich) Revenue ($) and Global Market Share from 2015-2020
Table Merck & Co. Inc. (Sigma Aldrich) RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global RNA-interference (RNAi) Production Value ($) by Region from 2015-2020
Table Global RNA-interference (RNAi) Production Value Share by Region from 2015-2020
Table Global RNA-interference (RNAi) Production by Region from 2015-2020
Table Global RNA-interference (RNAi) Consumption Value ($) by Region from 2015-2020
Table Global RNA-interference (RNAi) Consumption by Region from 2015-2020
Table North America RNA-interference (RNAi) Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America RNA-interference (RNAi) Import and Export from 2015-2020
Table North America RNA-interference (RNAi) Value ($) by Type (2015-2020)
Table North America RNA-interference (RNAi) Production by Type (2015-2020)
Table North America RNA-interference (RNAi) Consumption by Application (2015-2020)
Table North America RNA-interference (RNAi) Consumption by Country (2015-2020)
Table North America RNA-interference (RNAi) Consumption Value ($) by Country (2015-2020)
Figure North America RNA-interference (RNAi) Market PEST Analysis
Table Europe RNA-interference (RNAi) Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe RNA-interference (RNAi) Import and Export from 2015-2020
Table Europe RNA-interference (RNAi) Value ($) by Type (2015-2020)
Table Europe RNA-interference (RNAi) Production by Type (2015-2020)
Table Europe RNA-interference (RNAi) Consumption by Application (2015-2020)
Table Europe RNA-interference (RNAi) Consumption by Country (2015-2020)
Table Europe RNA-interference (RNAi) Consumption Value ($) by Country (2015-2020)
Figure Europe RNA-interference (RNAi) Market PEST Analysis
Table Asia-Pacific RNA-interference (RNAi) Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific RNA-interference (RNAi) Import and Export from 2015-2020
Table Asia-Pacific RNA-interference (RNAi) Value ($) by Type (2015-2020)
Table Asia-Pacific RNA-interference (RNAi) Production by Type (2015-2020)
Table Asia-Pacific RNA-interference (RNAi) Consumption by Application (2015-2020)
Table Asia-Pacific RNA-interference (RNAi) Consumption by Country (2015-2020)
Table Asia-Pacific RNA-interference (RNAi) Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific RNA-interference (RNAi) Market PEST Analysis
Table Latin America RNA-interference (RNAi) Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America RNA-interference (RNAi) Import and Export from 2015-2020
Table Latin America RNA-interference (RNAi) Value ($) by Type (2015-2020)
Table Latin America RNA-interference (RNAi) Production by Type (2015-2020)
Table Latin America RNA-interference (RNAi) Consumption by Application (2015-2020)
Table Latin America RNA-interference (RNAi) Consumption by Country (2015-2020)
Table Latin America RNA-interference (RNAi) Consumption Value ($) by Country (2015-2020)
Figure Latin America RNA-interference (RNAi) Market PEST Analysis
Table Middle East & Africa RNA-interference (RNAi) Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa RNA-interference (RNAi) Import and Export from 2015-2020
Table Middle East & Africa RNA-interference (RNAi) Value ($) by Type (2015-2020)
Table Middle East & Africa RNA-interference (RNAi) Production by Type (2015-2020)
Table Middle East & Africa RNA-interference (RNAi) Consumption by Application (2015-2020)
Table Middle East & Africa RNA-interference (RNAi) Consumption by Country (2015-2020)
Table Middle East & Africa RNA-interference (RNAi) Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa RNA-interference (RNAi) Market PEST Analysis
Table Global RNA-interference (RNAi) Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global RNA-interference (RNAi) Production and Growth Rate Forecast by Region (2020-2027)
Table Global RNA-interference (RNAi) Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global RNA-interference (RNAi) Production and Growth Rate Forecast by Type (2020-2027)
Table Global RNA-interference (RNAi) Consumption and Growth Rate Forecast by Application (2020-2027)
Global RNA-interference (RNAi) Market Value ($) and Growth Rate of RNA-interference (RNAi) from 2015-2027
Global RNA-interference (RNAi) Production and Growth Rate Segment by Product Type from 2015-2027
Global RNA-interference (RNAi) Consumption and Growth Rate Segment by Application from 2015-2027
Figure RNA-interference (RNAi) Picture
Table Product Specifications of RNA-interference (RNAi)
Table Driving Factors for this Market
Table Industry News of RNA-interference (RNAi) Market
Figure Value Chain Status of RNA-interference (RNAi)
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global RNA-interference (RNAi) Production and Growth Rate Segment by Product Type from 2015-2020
Table Global RNA-interference (RNAi) Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Chemical synthesis of RNA-interference (RNAi)
Figure In vitro transcription of RNA-interference (RNAi)
Figure In vivo expression of RNA-interference (RNAi)
Table Global RNA-interference (RNAi) Consumption and Growth Rate Segment by Application from 2015-2020
Table Global RNA-interference (RNAi) Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Drug Discovery and Development of RNA-interference (RNAi)
Figure Therapeutics of RNA-interference (RNAi)
Table Global RNA-interference (RNAi) Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global RNA-interference (RNAi) Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of RNA-interference (RNAi)
Figure Online Channel of RNA-interference (RNAi)
Table Thermo Fisher Scientific Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Thermo Fisher Scientific Inc. Sales and Growth Rate from 2015-2020
Figure Thermo Fisher Scientific Inc. Revenue ($) and Global Market Share from 2015-2020
Table Thermo Fisher Scientific Inc. RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Arcturus Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Arcturus Therapeutics Sales and Growth Rate from 2015-2020
Figure Arcturus Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Arcturus Therapeutics RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Qiagen NV Profile (Company Name, Plants Distribution, Sales Region)
Figure Qiagen NV Sales and Growth Rate from 2015-2020
Figure Qiagen NV Revenue ($) and Global Market Share from 2015-2020
Table Qiagen NV RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Silence Therapeutics PLC Profile (Company Name, Plants Distribution, Sales Region)
Figure Silence Therapeutics PLC Sales and Growth Rate from 2015-2020
Figure Silence Therapeutics PLC Revenue ($) and Global Market Share from 2015-2020
Table Silence Therapeutics PLC RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Alnylam Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Alnylam Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Alnylam Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Alnylam Pharmaceuticals RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Benitec Biopharma Ltd Profile (Company Name, Plants Distribution, Sales Region)
Figure Benitec Biopharma Ltd Sales and Growth Rate from 2015-2020
Figure Benitec Biopharma Ltd Revenue ($) and Global Market Share from 2015-2020
Table Benitec Biopharma Ltd RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Phio Pharmaceuticals Corp. Profile (Company Name, Plants Distribution, Sales Region)
Figure Phio Pharmaceuticals Corp. Sales and Growth Rate from 2015-2020
Figure Phio Pharmaceuticals Corp. Revenue ($) and Global Market Share from 2015-2020
Table Phio Pharmaceuticals Corp. RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Arrowhead Profile (Company Name, Plants Distribution, Sales Region)
Figure Arrowhead Sales and Growth Rate from 2015-2020
Figure Arrowhead Revenue ($) and Global Market Share from 2015-2020
Table Arrowhead RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ionis Pharmaceuticals Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Ionis Pharmaceuticals Inc. Sales and Growth Rate from 2015-2020
Figure Ionis Pharmaceuticals Inc. Revenue ($) and Global Market Share from 2015-2020
Table Ionis Pharmaceuticals Inc. RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Quark Pharmaceuticals Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Quark Pharmaceuticals Inc. Sales and Growth Rate from 2015-2020
Figure Quark Pharmaceuticals Inc. Revenue ($) and Global Market Share from 2015-2020
Table Quark Pharmaceuticals Inc. RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Tekmira Pharmaceuticals Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Tekmira Pharmaceuticals Corporation Sales and Growth Rate from 2015-2020
Figure Tekmira Pharmaceuticals Corporation Revenue ($) and Global Market Share from 2015-2020
Table Tekmira Pharmaceuticals Corporation RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table RXI Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure RXI Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure RXI Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table RXI Pharmaceuticals RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table ISIS Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure ISIS Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure ISIS Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table ISIS Pharmaceuticals RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Dicerna Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Dicerna Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Dicerna Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Dicerna Pharmaceuticals RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck & Co. Inc. (Sigma Aldrich) Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck & Co. Inc. (Sigma Aldrich) Sales and Growth Rate from 2015-2020
Figure Merck & Co. Inc. (Sigma Aldrich) Revenue ($) and Global Market Share from 2015-2020
Table Merck & Co. Inc. (Sigma Aldrich) RNA-interference (RNAi) Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global RNA-interference (RNAi) Production Value ($) by Region from 2015-2020
Table Global RNA-interference (RNAi) Production Value Share by Region from 2015-2020
Table Global RNA-interference (RNAi) Production by Region from 2015-2020
Table Global RNA-interference (RNAi) Consumption Value ($) by Region from 2015-2020
Table Global RNA-interference (RNAi) Consumption by Region from 2015-2020
Table North America RNA-interference (RNAi) Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America RNA-interference (RNAi) Import and Export from 2015-2020
Table North America RNA-interference (RNAi) Value ($) by Type (2015-2020)
Table North America RNA-interference (RNAi) Production by Type (2015-2020)
Table North America RNA-interference (RNAi) Consumption by Application (2015-2020)
Table North America RNA-interference (RNAi) Consumption by Country (2015-2020)
Table North America RNA-interference (RNAi) Consumption Value ($) by Country (2015-2020)
Figure North America RNA-interference (RNAi) Market PEST Analysis
Table Europe RNA-interference (RNAi) Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe RNA-interference (RNAi) Import and Export from 2015-2020
Table Europe RNA-interference (RNAi) Value ($) by Type (2015-2020)
Table Europe RNA-interference (RNAi) Production by Type (2015-2020)
Table Europe RNA-interference (RNAi) Consumption by Application (2015-2020)
Table Europe RNA-interference (RNAi) Consumption by Country (2015-2020)
Table Europe RNA-interference (RNAi) Consumption Value ($) by Country (2015-2020)
Figure Europe RNA-interference (RNAi) Market PEST Analysis
Table Asia-Pacific RNA-interference (RNAi) Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific RNA-interference (RNAi) Import and Export from 2015-2020
Table Asia-Pacific RNA-interference (RNAi) Value ($) by Type (2015-2020)
Table Asia-Pacific RNA-interference (RNAi) Production by Type (2015-2020)
Table Asia-Pacific RNA-interference (RNAi) Consumption by Application (2015-2020)
Table Asia-Pacific RNA-interference (RNAi) Consumption by Country (2015-2020)
Table Asia-Pacific RNA-interference (RNAi) Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific RNA-interference (RNAi) Market PEST Analysis
Table Latin America RNA-interference (RNAi) Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America RNA-interference (RNAi) Import and Export from 2015-2020
Table Latin America RNA-interference (RNAi) Value ($) by Type (2015-2020)
Table Latin America RNA-interference (RNAi) Production by Type (2015-2020)
Table Latin America RNA-interference (RNAi) Consumption by Application (2015-2020)
Table Latin America RNA-interference (RNAi) Consumption by Country (2015-2020)
Table Latin America RNA-interference (RNAi) Consumption Value ($) by Country (2015-2020)
Figure Latin America RNA-interference (RNAi) Market PEST Analysis
Table Middle East & Africa RNA-interference (RNAi) Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa RNA-interference (RNAi) Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa RNA-interference (RNAi) Import and Export from 2015-2020
Table Middle East & Africa RNA-interference (RNAi) Value ($) by Type (2015-2020)
Table Middle East & Africa RNA-interference (RNAi) Production by Type (2015-2020)
Table Middle East & Africa RNA-interference (RNAi) Consumption by Application (2015-2020)
Table Middle East & Africa RNA-interference (RNAi) Consumption by Country (2015-2020)
Table Middle East & Africa RNA-interference (RNAi) Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa RNA-interference (RNAi) Market PEST Analysis
Table Global RNA-interference (RNAi) Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global RNA-interference (RNAi) Production and Growth Rate Forecast by Region (2020-2027)
Table Global RNA-interference (RNAi) Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global RNA-interference (RNAi) Production and Growth Rate Forecast by Type (2020-2027)
Table Global RNA-interference (RNAi) Consumption and Growth Rate Forecast by Application (2020-2027)
